BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16900471)

  • 1. Dutch solutions for liquid-based cytology: analysis of unsatisfactory slides and HPV testing of equivocal cytology.
    Boon ME; Rijkaart DC; Ouwerkerk-Noordam E; Korporaal H
    Diagn Cytopathol; 2006 Sep; 34(9):644-8. PubMed ID: 16900471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi.
    Depuydt CE; Benoy IH; Bailleul EJ; Vandepitte J; Vereecken AJ; Bogers JJ
    Cytopathology; 2006 Dec; 17(6):374-81. PubMed ID: 17168921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China.
    Zhao FH; Hu SY; Bian JJ; Liu B; Peck RB; Bao YP; Pan QJ; Frappart L; Sellors J; Qiao YL
    Cancer Cytopathol; 2011 Dec; 119(6):387-94. PubMed ID: 21774094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes and relevance of unsatisfactory and satisfactory but limited smears of liquid-based compared with conventional cervical cytology.
    Siebers AG; Klinkhamer PJ; Vedder JE; Arbyn M; Bulten J
    Arch Pathol Lab Med; 2012 Jan; 136(1):76-83. PubMed ID: 22208490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
    Wright TC
    Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid-based cytology for cervical cancer screening.
    Bentz JS
    Expert Rev Mol Diagn; 2005 Nov; 5(6):857-71. PubMed ID: 16255628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novaprep(®) Vial Test is a suitable liquid-based cytology medium for high risk human papillomavirus testing by Hybrid Capture 2.
    Prétet JL; Vidal C; Le Bail Carval K; Ramanah R; Carcopino X; Cartier I; Labouyrie E; Kantelip B; Coumes-Marquet S; Riethmuller D; Mougin C
    J Clin Virol; 2010 Dec; 49(4):286-9. PubMed ID: 20884288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance and cost analysis of Siriraj liquid-based cytology: a direct-to-vial study.
    Laiwejpithaya S; Benjapibal M; Laiwejpithaya S; Wongtiraporn W; Sangkarat S; Rattanachaiyanont M
    Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):201-5. PubMed ID: 19747757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
    Cibas ES; Hong X; Crum CP; Feldman S
    Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
    Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
    Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment.
    Ronco G; Brezzi S; Carozzi F; Dalla Palma P; Giorgi-Rossi P; Minucci D; Naldoni C; Segnan N; Zappa M; Zorzi M; Cuzick J;
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S230-2. PubMed ID: 17822751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of the cytology laboratory: specimen processing through diagnosis.
    Joste N
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):549-63; viii. PubMed ID: 19061816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two cytological methods for screening for cervical cancer].
    Kirschner B; Simonsen K; Junge J
    Ugeskr Laeger; 2008 May; 170(22):1933-7. PubMed ID: 18513478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of human papillomavirus genotyping in cervical liquid-based cytology specimens; using the Roche Linear Array HPV genotyping assay.
    Jamison J; Wilson RT; Carson J
    Cytopathology; 2009 Aug; 20(4):242-8. PubMed ID: 19291176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid-based cytology can improve efficiency of cervical smear readers: evidence from timing surveys in two NHS cytology laboratories.
    Dowie R; Stoykova B; Crawford D; Desai M; Mather J; Morgan K; Shirt M
    Cytopathology; 2006 Apr; 17(2):65-72. PubMed ID: 16548990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening in the early post vaccine era.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low prevalence of high-risk HPV in older women not attending organized cytological screening: a pilot study.
    Wikström I; Stenvall H; Wilander E
    Acta Derm Venereol; 2007; 87(6):554-5. PubMed ID: 17989903
    [No Abstract]   [Full Text] [Related]  

  • 19. HPV testing for cervical cancer screening in Croatia.
    Grce M; Grahovac B; Rukavina T; Vrdoljak-Mozetic D; Glavas-Obrovac L; Kaliterna V; Zele-Starcević L
    Coll Antropol; 2007 Apr; 31 Suppl 2():67-71. PubMed ID: 17598507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colposcopy, cervical screening, and HPV. Preface.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):xv-xvi. PubMed ID: 19061813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.